Author details

Full Name

John N Weinstein

Affiliation

The University of Texas MD Anderson Cancer Center

ORCID

Career Start Year

1968

Papers

322

H Index

104

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
32341528	Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.	Nat Genet	2023
37627071	Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images.	Cancers (Basel)	2023
37873318	DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples.	bioRxiv	2023
37069167	Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis.	Nat Commun	2023
32047324	Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.	Nat Genet	2023
32341528	Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.	Nat Genet	2023
37627071	Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images.	Cancers (Basel)	2023
37873318	DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples.	bioRxiv	2023
37069167	Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis.	Nat Commun	2023
32047324	Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.	Nat Genet	2023
36205581	RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data.	Bioinformatics	2022
35811851	Erratum: The origin of bladder cancer from mucosal field effects.	iScience	2022
36205581	RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data.	Bioinformatics	2022
35811851	Erratum: The origin of bladder cancer from mucosal field effects.	iScience	2022
34247201	Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway.	Cell Death Dis	2021
33626341	Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.	Cell Rep	2021
34247201	Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway.	Cell Death Dis	2021
33626341	Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.	Cell Rep	2021
32521509	Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.	iScience	2020
32024997	Comprehensive molecular characterization of mitochondrial genomes in human cancers.	Nat Genet	2020
32364696	Mechanism of Catalysis by l-Asparaginase.	Biochemistry	2020
32037144	Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.	Eur Urol	2020
32546765	Assessment of Luminal and Basal Phenotypes in Bladder Cancer.	Sci Rep	2020
32521509	Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.	iScience	2020
32636365	A user guide for the online exploration and visualization of PCAWG data.	Nat Commun	2020
32024997	Comprehensive molecular characterization of mitochondrial genomes in human cancers.	Nat Genet	2020
32037144	Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.	Eur Urol	2020
32636365	A user guide for the online exploration and visualization of PCAWG data.	Nat Commun	2020
32364696	Mechanism of Catalysis by l-Asparaginase.	Biochemistry	2020
32546765	Assessment of Luminal and Basal Phenotypes in Bladder Cancer.	Sci Rep	2020
30634463	Assessment of l-Asparaginase Pharmacodynamics in Mouse Models of Cancer.	Metabolites	2019
30634463	Assessment of l-Asparaginase Pharmacodynamics in Mouse Models of Cancer.	Metabolites	2019
31509758	Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.	Cell Rep	2019
31433971	The Immune Landscape of Cancer.	Immunity	2019
30851108	Response envelope analysis for quantitative evaluation of drug combinations.	Bioinformatics	2019
31209181	Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.	Mol Cancer Ther	2019
31365877	Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.	Cell Rep	2019
30784602	Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.	Cell Rep	2019
31106233	ZC3H12A Expression in Different Stages of Colorectal Cancer.	Oncoscience	2019
30782135	ElemCor: accurate data analysis and enrichment calculation for high-resolution LC-MS stable isotope labeling experiments.	BMC Bioinformatics	2019
30988467	Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.	Nat Methods	2019
31209181	Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.	Mol Cancer Ther	2019
31433971	The Immune Landscape of Cancer.	Immunity	2019
31509758	Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.	Cell Rep	2019
31365877	Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.	Cell Rep	2019
30988467	Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.	Nat Methods	2019
30851108	Response envelope analysis for quantitative evaluation of drug combinations.	Bioinformatics	2019
31106233	ZC3H12A Expression in Different Stages of Colorectal Cancer.	Oncoscience	2019
30784602	Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.	Cell Rep	2019
30782135	ElemCor: accurate data analysis and enrichment calculation for high-resolution LC-MS stable isotope labeling experiments.	BMC Bioinformatics	2019

1 - 50 of 644

Nehme El-Hachem

Centre Hospitalier Universitaire Sainte-Justine Research Centre

Career Start Year 2011

Number of shared co-authors 2

Eric Paquet

University of Laval

Career Start Year 2007

Number of shared co-authors 0

Pingfu Fu

Case Western Reserve University

Career Start Year 2000

Number of shared co-authors 9

David J Liewehr

Center for Cancer Research

Career Start Year 1999

Number of shared co-authors 12

Kerby Shedden

University of Michigan ann arbor

Career Start Year 1999

Number of shared co-authors 4

Dongquan Chen

University of Alabama at Birmingham

Career Start Year 1997

Number of shared co-authors 4

Kaylene J Simpson

The University of Melbourne, Peter MacCallum Cancer Centre

Career Start Year 1996

Number of shared co-authors 4

William M Gallagher

All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin

Career Start Year 1996

Number of shared co-authors 13

David de Graaf

Syntimmune Inc.

Career Start Year 1995

Number of shared co-authors 3

Roland Eils

Berlin Institute of Health (BIH) and Charite

Career Start Year 1995

Number of shared co-authors 42

Jeremy S Caldwell

Sirna Therapeutics a former subsidiary of Merck & Co., Inc.

Career Start Year 1994

Number of shared co-authors 0

Peter Kuhn

University of Tubingen

Career Start Year 1994

Number of shared co-authors 5

Timothy A Lewis

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 1990

Number of shared co-authors 8

Katherine Stemke-Hale

MD Anderson Cancer Center, University of Texas

Career Start Year 1989

Number of shared co-authors 34

Emile E Voest

The Netherlands Cancer Institute

Career Start Year 1989

Number of shared co-authors 10

Roger Chammas

Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo

Career Start Year 1989

Number of shared co-authors 1

Philip J R Day

University of Cape Town

Career Start Year 1988

Number of shared co-authors 5

Eivind Hovig

Center for Bioinformatics, University of Oslo

Career Start Year 1987

Number of shared co-authors 21

Stefan W??lfl

Institute of Pharmacy and Molecular Biotechnology, Heidelberg University

Career Start Year 1987

Number of shared co-authors 0

Seth M Steinberg

Center for Cancer Research, National Cancer Institute

Career Start Year 1984

Number of shared co-authors 27

Adrian L Harris

University of Oxford

Career Start Year 1981

Number of shared co-authors 26

Fabien Calvo

Universite de Paris-Cite

Career Start Year 1979

Number of shared co-authors 7

Alexander Kamb

Inc. 30301 Agoura Rd.

Career Start Year 1979

Number of shared co-authors 1

Robert H Shoemaker

National Cancer Institute

Career Start Year 1978

Number of shared co-authors 15

Samir M Hanash

University of Texas MD Anderson Cancer Center

Career Start Year 1977

Number of shared co-authors 35

David W Hedley

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1975

Number of shared co-authors 3

William E Grizzle

University of Alabama at Birmingham

Career Start Year 1974

Number of shared co-authors 7

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 65

Karin D Rodland

Oregon Health and Science University

Career Start Year 1973

Number of shared co-authors 17

Edouard C Nice

Monash University

Career Start Year 1971

Number of shared co-authors 5

row(s) 1 - 30 of 30